Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
- PMID: 23266198
- PMCID: PMC3552326
- DOI: 10.1016/j.ymgme.2012.11.010
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
Abstract
Mutations in GBA, the gene encoding glucocerebrosidase, the lysosomal enzyme deficient in Gaucher disease increase the risk for developing Parkinson disease. Recent research suggests a relationship between glucocerebrosidase and the Parkinson disease-related amyloid-forming protein, α-synuclein; however, the specific molecular mechanisms responsible for association remain elusive. Previously, we showed that α-synuclein and glucocerebrosidase interact selectively under lysosomal conditions, and proposed that this newly identified interaction might influence cellular levels of α-synuclein by either promoting protein degradation and/or preventing aggregation. Here, we demonstrate that membrane-bound α-synuclein interacts with glucocerebrosidase, and that this complex formation inhibits enzyme function. Using site-specific fluorescence and Förster energy transfer probes, we mapped the protein-enzyme interacting regions on unilamellar vesicles. Our data suggest that on the membrane surface, the glucocerebrosidase-α-synuclein interaction involves a larger α-synuclein region compared to that found in solution. In addition, α-synuclein acts as a mixed inhibitor with an apparent IC(50) in the submicromolar range. Importantly, the membrane-bound, α-helical form of α-synuclein is necessary for inhibition. This glucocerebrosidase interaction and inhibition likely contribute to the mechanism underlying GBA-associated parkinsonism.
Published by Elsevier Inc.
Figures
Similar articles
-
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases.J Biol Chem. 2011 Aug 12;286(32):28080-8. doi: 10.1074/jbc.M111.237859. Epub 2011 Jun 8. J Biol Chem. 2011. PMID: 21653695 Free PMC article.
-
Saposin C protects glucocerebrosidase against α-synuclein inhibition.Biochemistry. 2013 Oct 15;52(41):7161-3. doi: 10.1021/bi401191v. Epub 2013 Oct 1. Biochemistry. 2013. PMID: 24070323 Free PMC article.
-
Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.J Biol Chem. 2015 Jan 9;290(2):744-54. doi: 10.1074/jbc.M114.610584. Epub 2014 Nov 26. J Biol Chem. 2015. PMID: 25429104 Free PMC article.
-
Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.J Neurochem. 2016 Oct;139 Suppl 1:198-215. doi: 10.1111/jnc.13517. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860955 Review.
-
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.Neuroscientist. 2018 Oct;24(5):540-559. doi: 10.1177/1073858417748875. Epub 2018 Feb 4. Neuroscientist. 2018. PMID: 29400127 Review.
Cited by
-
Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells.Int J Mol Sci. 2023 Jun 24;24(13):10589. doi: 10.3390/ijms241310589. Int J Mol Sci. 2023. PMID: 37445771 Free PMC article.
-
GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance.Int J Mol Sci. 2023 Jan 20;24(3):2044. doi: 10.3390/ijms24032044. Int J Mol Sci. 2023. PMID: 36768367 Free PMC article. Review.
-
The Consequences of GBA Deficiency in the Autophagy-Lysosome System in Parkinson's Disease Associated with GBA.Cells. 2023 Jan 3;12(1):191. doi: 10.3390/cells12010191. Cells. 2023. PMID: 36611984 Free PMC article. Review.
-
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.Int J Mol Sci. 2022 Oct 9;23(19):12004. doi: 10.3390/ijms231912004. Int J Mol Sci. 2022. PMID: 36233303 Free PMC article.
-
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992201 Free PMC article. Review.
References
-
- Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, DiIorio G, Golbe LI, Nussbaum RL. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047. - PubMed
-
- Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. Ala30pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nature Genet. 1998;18:106–108. - PubMed
-
- Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Tortosa EG, del Ser T, Munoz DG, de Yebenes JG. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164–173. - PubMed
-
- Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. α-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302:841–841. - PubMed
-
- Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A. α-Synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet. 2004;364:1167–1169. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
